SCHEMBL2031599

SCHEMBL2031599

CC(CO)(CO)C(=O)[O-].[Na+]

nearest known ligand 0.38

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 2/20 0.38
CA1 known ✓ P00915 3/20 0.37
CA4 known ✓ P22748 4/20 0.36
FFAR3 O14843 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32
CASP1 P29466 1/20 0.32
FAHD1 Q6P587 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5144808 0.94 CYP2D6 (0.32) CA2CA1CA4CYP2D6TSHR
Zinc Ion SCHEMBL5144410 0.94 CYP2D6 (0.32) CA2CA1CA4CYP2D6TSHR
SCHEMBL5080079 0.94 CYP2D6 (0.32) CA2CA1CA4CYP2D6TSHR
SCHEMBL5142314 0.94 CYP2D6 (0.32) CA2CA1CA4CYP2D6TSHR
Potassium Ion SCHEMBL2701663 0.94 CA4 (0.35) CA2CA1CA4CYP2D6TSHR
SCHEMBL5144685 0.94 CYP2D6 (0.32) CA2CA1CA4CYP2D6TSHR
Lithium Ion SCHEMBL5144788 0.94 CYP2D6 (0.32) CA2CA1CA4CYP2D6TSHR
SCHEMBL5080076 0.94 CYP2D6 (0.32) CA2CA1CA4CYP2D6TSHR
SCHEMBL5165796 0.94 CYP2D6 (0.32) CA2CA1CA4CYP2D6TSHR
Silver SCHEMBL979870 0.94 CYP2D6 (0.32) CA2CA1CA4CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 81 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118388733-A Flame-retardant waterborne polyurethane for impregnating microfiber leather and preparation method of flame-retardant microfiber leather 明新旭腾新材料股份有限公司 2024-07-26 CN claimed
CN-113072832-B Combined rheology modifier and preparation method and application thereof 万华化学集团股份有限公司 2023-03-03 CN claimed
CN-113072832-A Combined rheology modifier and preparation method and application thereof 万华化学集团股份有限公司 2021-07-06 CN claimed
JP-1256563-A None JP disclosed
JP-1256561-A None JP disclosed
JP-1256562-A None JP disclosed
JP-6192169-A None JP disclosed
JP-3277655-A None JP disclosed
US-20260011737-A1 ELECTRODE BINDER FOR LITHIUM SECONDARY BATTERY, ELECTRODE BINDER COMPOSITION, NEGATIVE ELECTRODE, AND LITHIUM SECONDARY BATTERY DKS CO. LTD. (JP) 2026-01-08 US disclosed
EP-4557405-A1 LITHIUM SECONDARY BATTERY ELECTRODE BINDER, ELECTRODE BINDER COMPOSITION, NEGATIVE ELECTRODE, AND LITHIUM SECONDARY BATTERY DKS Co. Ltd. (JP) 2025-05-21 EP disclosed
CN-118388733-A Flame-retardant waterborne polyurethane for impregnating microfiber leather and preparation method of flame-retardant microfiber leather 明新旭腾新材料股份有限公司 2024-07-26 CN disclosed
EP-0549849-A1 Magnetic paint and objects coated with same DAINIPPON INK AND CHEMICALS, INC. (JP) 1993-07-07 EP disclosed
JP-H03277655-A FIBER-REINFORCED COPOLYESTER COMPOSITION IDEMITSU PETROCHEM CO LTD 1991-12-09 JP disclosed
EP-0435264-A1 Binders for powder and magnetic recording media using same NIPPON ZEON CO., LTD. (JP) 1991-07-03 EP disclosed
US-4931595-A Catalytic hydrolysis process for polyamines BAYER AKTIENGESELLSCHAFT (DE) 1990-06-05 US disclosed
JP-H01256562-A GLASS FIBER-REINFORCED POLYESTER RESIN COMPOSITION OF EXCELLENT LOW-TEMPERATURE CRYSTALLIZABILITY KURARAY CO LTD 1989-10-13 JP disclosed
JP-H01256563-A GLASS FIBER-REINFORCED POLYESTER RESIN COMPOSITION EXCELLENT IN TOUGHNESS AND CRYSTALLIZABILITY KURARAY CO LTD 1989-10-13 JP disclosed
JP-H01256561-A GLASS FIBER-REINFORCED POLYESTER RESIN COMPOSITION OF EXCELLENT CRYSTALLIZABILITY KURARAY CO LTD 1989-10-13 JP disclosed
US-4716119-A REDUCTION OF TURBIDITY IN RECONSTITUTED LYOPHILIZED SAMPLE BOEHRINGER MANNHEIM GMBH (DE) 1987-12-29 US disclosed
EP-0058959-A1 Method for preparing low-turbidity standard or reference sera Roche Diagnostics GmbH (DE) 1982-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260011737-A1 ELECTRODE BINDER FOR LITHIUM SECONDARY BATTERY, ELECTRODE BINDER COMPOSITION, NEGATIVE ELECTRODE, AND LITHIUM SECONDARY BATTERY SCO2, CACNA1C, SCNN1B CA2 51/4885CA1 59/4885CA4 185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.